Sign in

Joseph Moskowitz

Director at AFLACAFLAC
Board

About Joseph L. Moskowitz

Independent director of Aflac Incorporated since 2015, age 71, and currently Chair of the Compensation Committee as well as a Financial Expert on the Audit & Risk Committee . Background includes four decades in insurance and actuarial leadership: retired EVP at Primerica leading product economics and financial analysis; prior Chief Actuary at Primerica; VP at Sun Life; and Senior Manager at KPMG . Professional credentials: Fellow of the Society of Actuaries (since 1979) and Member of the American Academy of Actuaries (since 1979) . The Board has determined he is independent under NYSE standards .

Past Roles

OrganizationRoleTenureCommittees/Impact
Primerica, Inc.Executive Vice President; led Product Economics & Financial Analysis2009–2014 Managed budgeting, capital support, earnings analysis, and investor communications; actuarial leadership
Primerica, Inc.Chief Actuary1999–2004 Led actuarial function; core to financial reporting and risk assessment
Sun Life Insurance CompanyVice President1985–1988 Senior insurance leadership
KPMGSenior Manager1979–1985 Audit/financial experience; actuarial and financial modeling foundation

External Roles

OrganizationRoleTenureNotes
Society of ActuariesFellowSince 1979 Professional credential (FSA)
American Academy of ActuariesMemberSince 1979 Professional credential (MAAA)

Board Governance

  • Committee assignments: Audit & Risk (member; Financial Expert), Compensation (Chair), Corporate Development (member), Executive (member) .
  • Independence: Board determined all non-employee nominees (including Moskowitz) are independent under NYSE standards .
  • Attendance and engagement: The Board met 4 times in 2024; all directors attended at least 75% of Board and committee meetings for their service period; directors attended the 2024 Annual Meeting .
  • Committee activity (2024 meetings): Audit & Risk (9), Compensation (4), Corporate Development (2), Executive (3) .
  • Lead Independent Director framework: Aflac maintains a Lead Non-Management Director role with defined authority over agendas and executive sessions; executive sessions conducted regularly .

Fixed Compensation (Director pay – 2024)

ComponentAmount (USD)Notes
Annual cash retainer$135,000 Standard non-employee director retainer
Audit & Risk Committee member fee$15,000 Applies to all AR members
Compensation Committee Chair fee$25,000 Applies to committee chairs (non-AR chair)
Total fees earned (cash)$175,000 Matches director compensation table

Performance Compensation (Director equity – 2024)

Grant DateFormShares/UnitsGrant Fair Value (USD)Vesting
May 6, 2024Restricted stock2,156 (held as of 12/31/24) $180,051 (valued at $84.73 grant-date price) Annual director grants vest at next Annual Meeting, generally subject to continued service
Outstanding optionsStock options34,154 (outstanding; exercisable within 60 days) — (no 2024 option grant) Director options generally vest after one year

Aflac’s director equity program targets roughly $180,000 annually in restricted stock; directors can elect options or restricted stock in lieu of cash; 2024 annual director grants were made in restricted stock .

Other Directorships & Interlocks

CategoryDetails
Current public company boardsNone disclosed in Aflac’s proxy biography for Mr. Moskowitz
Compensation Committee interlocksNone; no member was an officer/employee; no interlocks involving Aflac executives in 2024

Expertise & Qualifications

  • 40+ years of actuarial and insurance leadership; deep expertise in actuarial and financial models underpinning planning, reporting, and risk assessment .
  • Recognized Financial Expert serving on Audit & Risk; supports oversight of financial reporting, internal controls, and risk management .
  • Professional credentials (FSA, MAAA) demonstrate technical rigor and alignment with insurance governance needs .

Equity Ownership

MetricValue
Beneficial ownership (shares)60,535
Percent of outstanding shares<0.1%
Voting rights (time-phased)367,921 votes (as of 2/25/2025)
Options exercisable within 60 days34,154
Unvested restricted stock2,156 (as of 12/31/2024)
Pledged sharesNone disclosed; no pledged shares reported for directors
Ownership guidelinesDirectors must hold ≥5x annual cash retainer; compliance tracked; directors either meet or are on track within the allowed timeframe
Hedging/pledging policiesAnti-hedging for all employees; officers/directors prohibited from pledging company stock; 10b5-1 plans require Compensation Committee approval

Governance Assessment

  • Board effectiveness: As Compensation Committee Chair, Moskowitz led a program that received strong shareholder support (2024 Say-on-Pay approval 96.4%), signaling alignment of pay with performance and investor expectations .
  • Independence and risk oversight: Independent Financial Expert on Audit & Risk; active committee participation (AR 9 meetings; Comp 4), supporting robust oversight of financial reporting and compensation risk .
  • Pay structure and alignment: Balanced director pay mix (cash + time-based equity) with ownership guidelines; restricted stock grants and anti-hedging/anti-pledging policies strengthen alignment with shareholders .
  • Conflicts and related-party exposure: No related person transactions disclosed involving Moskowitz; the proxy’s related party section does not list him .
  • Consultant independence: Mercer serves as independent compensation consultant to the committee; while Mercer affiliates provide other services to management, the committee assessed independence and found no conflict (total payments ≈0.10% of Mercer parent revenue) .

RED FLAGS: None disclosed specific to Mr. Moskowitz (no pledging, no related-party transactions, no attendance issues). Watch item: Ongoing monitoring of consultant independence given non-compensation services to affiliates, though assessed as independent by the committee .